Insulet Corporation (PODD)

Insulet Market Cap

Insulet has a market cap or net worth of $9.79 billion as of October 16, 2026. It is the 2,185th most valuable company in the world and the 770th biggest in the United States. Its market cap has decreased by 55.51% in one year.

• Market Cap: 9.79B
• Enterprise Value: 10.20B
• 1-Year Change: -55.51%
• Global Rank: #2,185
• Country Rank: #770 United States
• Category: Mid-Cap

Market Cap Chart

Chart

Since May 15, 2007, Insulet's market cap has increased from $393.10M to $9.79B, an increase of 2,389.41%. That is a compound annual growth rate of 17.99%.

Market Cap History

Date	Market Cap	% Change
Oct 16, 2026	9.79B	-51.06%
Dec 31, 2025	20.00B	9.19%
Dec 31, 2024	18.31B	20.87%
Dec 29, 2023	15.15B	-25.89%
Dec 30, 2022	20.45B	11.42%
Dec 31, 2021	18.35B	8.88%
Dec 31, 2020	16.85B	59.23%
Dec 31, 2019	10.58B	125.86%
Dec 31, 2018	4.69B	16.71%
Dec 29, 2017	4.02B	85.55%
Dec 30, 2016	2.16B	0.52%
Dec 31, 2015	2.15B	-16.67%
Dec 31, 2014	2.58B	27.66%
Dec 31, 2013	2.02B	97.96%
Dec 31, 2012	1.02B	14.53%
Dec 30, 2011	892.40M	37.59%
Dec 31, 2010	648.60M	47.51%
Dec 31, 2009	439.70M	105.18%
Dec 31, 2008	214.30M	-65.47%
Dec 31, 2007	620.60M	57.87%
May 15, 2007	393.10M	-

View and export this data all the way back to 2007. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Oct 16, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Oct 17, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
STERIS	21.71B
Zimmer Biomet Holdings	18.06B
Penumbra	12.63B
Smith & Nephew	12.09B
Globus Medical	10.51B
Bio-Rad Laboratories	9.75B
Glaukos	9.69B
Bio-Rad Laboratories	9.48B